Well, Aagami has done well this year and I am on a third trip to India with a new client. This is 4th clients visit this year and in this visit I will also be doing work for another two clients again first time for them. So this year has been a key that Aagami really arrived as the company.
We are not only supporting various clients but these are various types of clients. right from early stage Malaria therapeutic and prophylactic company, a Protein therapeutics clinical stage novel compounds, Molecular diagnostic in Cardiology, Clinical stage re-purposed molecule in Oncology, Re-purposing (Reprofiling) of molecules technology, Peptides API, Nanostructured Solar Cells, Natural oil based Mosquito repellents to novel dermal delivery based cosmeceuticals. Hence a full variety of different molecules and technological deals.
Also we have strengthened relationship with India based pManifold Business solutions and have started our market research analyst with them. We started doing this since February and so far it has gone well.
We are not only supporting various clients but these are various types of clients. right from early stage Malaria therapeutic and prophylactic company, a Protein therapeutics clinical stage novel compounds, Molecular diagnostic in Cardiology, Clinical stage re-purposed molecule in Oncology, Re-purposing (Reprofiling) of molecules technology, Peptides API, Nanostructured Solar Cells, Natural oil based Mosquito repellents to novel dermal delivery based cosmeceuticals. Hence a full variety of different molecules and technological deals.
Also we have strengthened relationship with India based pManifold Business solutions and have started our market research analyst with them. We started doing this since February and so far it has gone well.
